Author | Toby Eyre, MBChB, MRCP | OncLive

Author | Toby Eyre, MBChB, MRCP

Articles

Dr. Eyre on BTK Inhibitors in Combination With Venetoclax for MCL

September 07, 2018

Toby Eyre, MBChB, MRCP, consultant hematologist at Oxford University Hospitals NHS Trust, discusses the potential for BTK inhibitors to be used in combination with venetoclax for mantle cell lymphoma.

Dr. Eyre on Results of Venetoclax in Relapsed/Refractory MCL

August 09, 2018

Toby Eyre, MBChB, MRCP, consultant hematologist at Oxford University Hospitals NHS Trust, discusses the results of single-agent venetoclax (Venclexta) in patients with relapsed/refractory mantle cell lymphoma.

Dr. Eyre Discusses Venetoclax Monotherapy in MCL

July 10, 2018

Toby Eyre, MBChB, MRCP, consultant hematologist at Oxford University Hospitals NHS Foundation Trust, discusses venetoclax (Venclexta) monotherapy in patients with mantle cell lymphoma.

x